Skip to main content
Emily Blumberg, MD, Infectious Disease, Philadelphia, PA

EmilyABlumbergMD

Infectious Disease Philadelphia, PA

Transplant/Immunocompromised States

Professor of Medicine/Infectious Diseases

Dr. Blumberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Blumberg's full profile

Already have an account?

  • Office

    3400 Spruce Street
    3 Silverstein, Suite D
    Philadelphia, PA 19104
    Phone+1 215-662-6932
    Fax+1 215-662-7899

Summary

  • I am a board certified infectious diseases physician with a focus on infections in transplant patients.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1984 - 1987
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 1981 - 1984
  • New York University School of Medicine
    New York University School of MedicineClass of 1981

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1984 - Present
  • PA State Medical License
    PA State Medical License 1987 - 2024
  • IL State Medical License
    IL State Medical License 1981 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Philadelphia Magazine Castle Connolly, 2011-2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Top Doctors - Philadelphia Magazine Philadelphia Magazine

Publications & Presentations

PubMed

Journal Articles

  • Cytokine Profiles and Severity of Influenza Infection in Transplant Recipients  
    Janet Englund, Emily Blumberg, The Journal of Infectious Diseases
  • Twelve-Month Outcomes After Transplant of Hepatitis C–infected Kidneys into Uninfected Recipients: A Single-Group Trial  
    David S Goldberg, Roy D Bloom, Vishnu S Potluri, Susanna M Nazarian, Ali Naji, Emily A Blumberg, Peter L Abt, Peter P Reese, Matthew Levine, Paige Porrett, Melissa Ble..., Annals of Internal Medicine

Press Mentions

  • Penn Medicine-Led Team Receives $8 Million to Build on Success of Hepatitis C Kidney Transplantation Research
    Penn Medicine-Led Team Receives $8 Million to Build on Success of Hepatitis C Kidney Transplantation ResearchJanuary 4th, 2022
  • Penn-Led Team Receives $8 Million to Build on Success of Hepatitis C Kidney Transplantation Research
    Penn-Led Team Receives $8 Million to Build on Success of Hepatitis C Kidney Transplantation ResearchJanuary 4th, 2022
  • Takeda’s LIVTENCITY™ (Maribavir) Now Available for Certain Individuals Ages 12 Years and Older with Post-Transplant Cytomegalovirus (CMV) Infection/Disease in the United States
    Takeda’s LIVTENCITY™ (Maribavir) Now Available for Certain Individuals Ages 12 Years and Older with Post-Transplant Cytomegalovirus (CMV) Infection/Disease in the United StatesDecember 2nd, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish